✦ LIBER ✦

Rationales for intraperitoneal chemotherapy: Chemosensitivity testing and pharmacokinetic considerations—Clinical experience with intraperitoneal chemotherapy

✍ Scribed by K. H. Link; G. Hepp; U. Butzer; L. Staib; R. Kunz; J. Pillasch; F. Gansauge; Ch. Schaller; H. G. Beger

Book ID: 112792376
Publisher: Blackwell Publishing
Year: 1995
Tongue: German
Weight: 811 KB
Volume: 27
Category: Article
ISSN: 0001-544X
DOI: 10.1007/bf02602253

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary experience with a modified t

Preliminary experience with a modified tenckhoff catheter for intraperitoneal chemotherapy

✍ Dr. Hoa N. Nguyen; Hervy E. Averette; Lindsay Wyble; Bernd-Uwe Sevin; Daniel Don 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

This study reports our preliminary experience with a modified Tenckhoff catheter for intraperitoneal chemotherapy, primarily designed to be larger, longer, and have more perfusion holes. There were 137 catheters implanted in 125 ovarian cancer patients from June I988 to December 1990, among which 11

Cytoreductive Surgery and Intraoperative

Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study

✍ Eelco de Bree; Hilde Rosing; Dimitris Filis; John Romanos; Maria Melisssourgaki; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

Cytoreductive Surgery and Intraperitonea

Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Experience with 501 Procedures

✍ Edward A. Levine; John H. Stewart IV; Gregory B. Russell; Kim R. Geisinger; Bria 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 324 KB

Clinical course for patients with perito

Clinical course for patients with peritoneal carcinomatosis excluded from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

✍ Rodt, Anne; Svarrer, Rebekka; Iversen, Lene 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 175 KB

Activity of Pressurized Intraperitoneal

Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: Preliminary clinical experience

✍ Tempfer, Clemens B.; Celik, Ilknur; Solass, Wiebke; Buerkle, Bernd; Pabst, Urs G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 643 KB

A rationale for neoadjuvant systemic tre

A rationale for neoadjuvant systemic treatment followed by surgical assessment and intraperitoneal chemotherapy in patients presenting with non-surgically resectable ovarian or primary peritoneal cancers

✍ Maurie Markman; Jerome Belinson 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 167 KB